Biomm SA (Brazil) Performance
| BIOM3 Stock | BRL 7.88 0.23 2.84% |
The firm shows a Beta (market volatility) of 0.51, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Biomm SA's returns are expected to increase less than the market. However, during the bear market, the loss of holding Biomm SA is expected to be smaller as well. At this point, Biomm SA has a negative expected return of -0.38%. Please make sure to confirm Biomm SA's maximum drawdown, potential upside, and the relationship between the treynor ratio and value at risk , to decide if Biomm SA performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Biomm SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
| Begin Period Cash Flow | 57.4 M | |
| Total Cashflows From Investing Activities | 61.5 M |
Biomm |
Biomm SA Relative Risk vs. Return Landscape
If you would invest 1,030 in Biomm SA on September 5, 2024 and sell it today you would lose (242.00) from holding Biomm SA or give up 23.5% of portfolio value over 90 days. Biomm SA is generating negative expected returns and assumes 2.9216% volatility on return distribution over the 90 days horizon. Simply put, 26% of stocks are less volatile than Biomm, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Biomm SA Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biomm SA's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Biomm SA, and traders can use it to determine the average amount a Biomm SA's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1307
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BIOM3 |
Estimated Market Risk
| 2.92 actual daily | 26 74% of assets are more volatile |
Expected Return
| -0.38 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Biomm SA is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biomm SA by adding Biomm SA to a well-diversified portfolio.
Biomm SA Fundamentals Growth
Biomm Stock prices reflect investors' perceptions of the future prospects and financial health of Biomm SA, and Biomm SA fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biomm Stock performance.
| Return On Equity | -0.77 | |||
| Return On Asset | -0.15 | |||
| Profit Margin | (0.99) % | |||
| Operating Margin | (0.90) % | |||
| Current Valuation | 554.55 M | |||
| Shares Outstanding | 81.29 M | |||
| Price To Earning | (8.47) X | |||
| Price To Book | 3.63 X | |||
| Price To Sales | 4.40 X | |||
| Revenue | 107.09 M | |||
| EBITDA | (53.76 M) | |||
| Cash And Equivalents | 30.58 M | |||
| Cash Per Share | 1.36 X | |||
| Total Debt | 134.07 M | |||
| Debt To Equity | 1.08 % | |||
| Book Value Per Share | 1.65 X | |||
| Cash Flow From Operations | (93.78 M) | |||
| Earnings Per Share | (1.19) X | |||
| Total Asset | 369.83 M | |||
| Retained Earnings | (104 M) | |||
| Current Asset | 61 M | |||
| Current Liabilities | 20 M | |||
About Biomm SA Performance
Assessing Biomm SA's fundamental ratios provides investors with valuable insights into Biomm SA's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Biomm SA is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
It offers AFREZZA, a human insulin inhalation powder CONFORT CARE, a moisturizing foot cream GLARGILIN, a glargine insulin and HERZUMA, a trastuzumab. Biomm S.A. was founded in 2001 and is based in So Paulo, Brazil. BIOMM ON operates under Biotechnology classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 94 people.Things to note about Biomm SA performance evaluation
Checking the ongoing alerts about Biomm SA for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Biomm SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Biomm SA generated a negative expected return over the last 90 days | |
| The company reported the revenue of 107.09 M. Net Loss for the year was (80.26 M) with profit before overhead, payroll, taxes, and interest of 26.93 M. | |
| Biomm SA has accumulated about 30.58 M in cash with (93.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.36. | |
| Roughly 52.0% of the company shares are held by company insiders |
- Analyzing Biomm SA's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biomm SA's stock is overvalued or undervalued compared to its peers.
- Examining Biomm SA's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Biomm SA's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biomm SA's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Biomm SA's stock. These opinions can provide insight into Biomm SA's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Biomm Stock Analysis
When running Biomm SA's price analysis, check to measure Biomm SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomm SA is operating at the current time. Most of Biomm SA's value examination focuses on studying past and present price action to predict the probability of Biomm SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomm SA's price. Additionally, you may evaluate how the addition of Biomm SA to your portfolios can decrease your overall portfolio volatility.